The Venture Codex Logo

The Venture Codex

Overview

Innovative gene therapies for ophthalmic diseases using AAV technology.

Total Raised

N/A

Rounds

1

Links

Verticals

Biotechnology
Health Care
Therapeutics

Investment History

Team

Dr. Caroline Man Xu

Co-Founder and CEO

Chuck Vigneron

Business Management